P-SCN-Bn-DOTA (tBu) 4
P-SCN-Bn-DOTA (tBu) 4 is the derivative of DOTA. p-SCN-Bn-DOTA (tBu) 4 is the component of the Gd (III) -DOTA-IAC, which is a targeted magnetic resonance imaging (MRI) contrast agent for αvβ3 integrin receptor[1].
Product Specifications
CAS Number
1703752-99-1
UNSPSC
12352005
Target
Drug Intermediate
Type
Reference compound
Related Pathways
Others
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/p-scn-bn-dota-tbu-4.html
Smiles
O=C(CN1CCN(CCN(C(CN(CC1)CC(OC(C)(C)C)=O)CC2=CC=C(C=C2)N=C=S)CC(OC(C)(C)C)=O)CC(OC(C)(C)C)=O)OC(C)(C)C
Molecular Formula
C40H65N5O8S
Molecular Weight
776.04
References & Citations
[1]Kim YS, et al., Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent. Bioorg Med Chem Lett. 2015;25 (10) :2056-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog